目的：探讨VitalStim吞咽障碍治疗仪治疗脑卒中后吞咽障碍的疗效及安全性。方法：将80例脑卒中后吞咽障碍的患者随机分为观察组和对照组，每组各40例，对照组给予常规的脑卒中药物治疗及基础吞咽功能训练和摄食训练。观察组在对照组治疗的基础上加用VitalStim吞咽障碍治疗仪治疗。治疗前后对两组患者进行吞咽功能评级，并观察临床疗效以及不良反应。结果：治疗后两组患者吞咽功能均较治疗前改善，治疗后观察组吞咽功能明显优于对照组，差异均有统计学意义（P<0.05）。两组临床疗效比较，观察组总有效率为90.0%，对照组总有效率为72.5%，观察组疗效优于对照组，两组比较差异有统计学意义（P<0.05）。两组均无明显不良反应。结论：VitalStim吞咽障碍治疗仪治疗脑卒中后吞咽障碍疗效显著，且无不良反应，值得在临床中推广应用。%Objective:To investigate the efficacy and safety of theVitalStim swallowing therapy instrument in the treatment of dysphagia after stroke.Method:80 patients with dysphagia after stroke were randomly divided into observation group and control group,40 cases in each group.The control group was given conventional stroke medcine therapy and basic swallowing function training and feeding training.The observation group was added VitalStim swallowing therapy instrument based on the treatment in control group.The swallowing functional rating,the clinical effect and adverse reaction were observed before and after treatment in two groups.Result:After treatment,the swallowing function of two groups were improved compared with before treatment,the swallowing function of the observation group was significantly better than that of the control group,the differences were statistically significant(P<0.05). The total effective rate was 90%of observation group,better than 72.5%of control group,the difference was statistically significant(P<0.05). There were no obvious adverse reaction in two groups.Conclusion:VitalStim swallowing therapy instrument has significantly curative effect in the treatment of dysphagia after stroke,and no adverse reaction.It is worth in clinical application.
展开▼
